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Introduction
Cancer is one of the serious causes of death. 
according to WHO statistics in 2012, an estimated 8.2 
million people died from cancer worldwide. Lung cancer is 
the most common leading cause of cancer with 1.6 million 
deaths (Bermudes et al., 2002 ,Yildirim et al., 2015),which 
can be due to occurrence of metastasis in the early stages, 
delayed diagnosis and rapid progression of the cancer 
(Qiu et al., 2012). Lung cancer divides in two subgroups 
including small cell lung cancer (SCLC) and non-small 
cell lung cancer (NSCLC) by which the latter is more 
prevalent (Govindan et al., 2006). Conventional anticancer 
therapies such as surgery, chemotherapy and radiation 
therapy for people with advanced lung cancers is much less 
effective and therefore the development of more efficient 
strategies is appear to be necessary (Zhou et al., 2015). 
Gene therapy is a good choice for the handling of several 
diseases including cancer (Sun et al., 2007). Bacterial 
toxins can interfere in proliferation control, apoptosis and 
differentiation or even can cause cell death. In the latter 
strategy, cells are directly killed via the protein expressed 
by the toxin genes (Patyar et al., 2010).Cytolethal 
distending toxin (CDT) is a bacterial genotoxin produced 
by variety of gram-negative bacteria, like Actinobacillus 
actinomycetemcomitans that can damage tissue at distinct 
anatomical sites. Secreted tripartite protein is encoded by 
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an operon containing three genes namely cdt A, cdtB and 
cdtC. A and C subunits has binding to cell surface and B 
subunit possesses a catalytic role. In contrast to the A and 
C subunits  that have a high sequence diversity probably 
due to lifestyle and host niche of producing bacteria, 
subunit B has high sequence and structure homology to 
DNase I that bring about DNA damage after its delivery 
into cells. CDT degrades nuclear DNA in cells and also 
inhibits the proliferation of cells by induction of G2 cell 
cycle arrest and thereby apoptosis inevitably is raised. 
However, some believe that B subunit would be enough 
for ultimate performance (Bezine et al., 2014). Herein, 
we have investigated anticancer property of the catalytic 
subunit B of Aggregatibacter actinomycetemcomitans 
through transfection of A549 human lung adenocarcinoma 
cells using recombinant plasmid pcDNA3.1/CdtB.
Materials and Methods
Cell Cultures and Transfection
A549, human lung adenocarcinoma cells were 
maintained in DMEM/F12 media (Gibco) supplemented 
with antibiotics (50 IU/ml penicillin, 50 microgram g/ml 
streptomycin) and 5% fetal bovine serum (FBS). The cells 
were incubated at 37°C in 5% CO2 humidified incubator 
for growth. Cell were transfected with lipofectamin 2,000 
(Invitrogen) according to manufacture order.
1Department of Biotechnology, School of Medicine, 2Cellular and Molecular Biology Research Center, 3Department of 
Biotechnology, School of Advanced Technologies in Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran. *For 
Correspondence: Bandehpour@gmail.com
Hajar Yaghoobi et al
Asian Pacific Journal of Cancer Prevention, Vol 17, Cancer Control in Western Asia Special Issue, 2016300
Plasmid construction
Aggregatibacter actinomycetemcomitans 852bp 
fragment encoding catalytic subunit CdtB was synthesized 
according to the nucleotide sequences available from the 
National Center for Biotechnology Information (NCBI) 
database and subcloned into pcDNA3. 1+ vector using 
XhoI and XbaI restriction enzymes and made pcDNA3.1/
cdtB. Construct was selected in E. coli Top10 and Plasmid 
DNA was isolated using an Accuprep®Nano-Plus Plasmid 
Mini Extraction Kit (BIONEER, Korea).  Construct was 
verified by PCR using universal and specific primers and 
DNA sequencing. Primers used in this study are listed in 
Table 1.
Cytolethal distending toxin (CDT) transcription assay 
by RT-PCR
Twenty-four hours before transfection of cells, A549 
cell line were seeded into 6-well plates at a density of 
0.6 ×106 cell/well per well then treated with pcDNA3.1/
cdtB.  After 12 h, 24h and 48 h, total RNA was extracted 
from similarly  control and transfected cell line using 
Total RNA Purification Kit (Jena Bioscience, Germany), 
cdtB mRNA was changed to cDNA using Rocket Script 
RT Premix and poly-dT primer as reported by the 
manufacturer (BIONEER, Korea),  then amplified by PCR 
using specific primers.
Observation of morphologic changes in intoxicated cells 
using invert fluorescent microscopy
A549 cells (5× 105 cells/well) were seeded into 
12-well plates and treated with pcDNA3.1/cdtB After  24 
h, 48 h and 72 h the cells were analyzed and photographed 
by JULTM Smart fluorescent cell analyzer .
In vitro Cytotoxicity assay 
Evaluation of cell proliferation by MTT Assay
The number of viable A549 cell line after transfection 
was evaluated by the MTT (3-[4, 5-methylthiazol-2-yl] 
-2, 5-diphenyl-tetrazolium bromide) assay in the manner 
of Sargent and Taylor(Sargent and Taylor, 1989).Briefly, 
cells were seeded into 96-well plate (2 × 104 cells/well) 
and twenty-four hours kept for attachment. Set of plated 
cells was transfected in triplicate and this treatment was 
carried out on cells with minimum of 75% Confluence, 
after 24, 48, and 72 hours. 10 μl of MTT (5 mg/ml) was 
added on to each well and incubated for 3h at 37oC in 
a 5% CO2 incubator. After completing the incubation 
the MTT solution was removed and 100 μl of dimethyl 
sulfoxide (DMSO) was added to each well to solubilize the 
formazan. The absorbance at 570 nm was determined by 
ELISA reader. The reduction of cell proliferation (%) was 
calculated using the following formula: cell inhibition (%) 
= (1-A570of treated cells/A570 of control cells) ×100%.
 
Evaluation of A549 cell count and viability by trypan 
blue dye.
A549 cells were plated in 6-well plates (0.6×106cell/
well), incubated for 24 hours then were treated with 
pcDNA3.1/cdtB  as described in the MTT assay. 
Following incubation, in a humidified 5% CO2 incubator 
at 37°C for 48 hr, the supernatant pool was collected 
and adherent cells were trypsinized and collected. Cell 
viability was performed by the dye exclusion test with 
0.5% trypan blue using a hemocytometer. Both viable 
and nonviable cells were counted. A minimum of 200 
cells was counted for each data point in a total of five 
microscopic fields.
Necrosis and apoptosis assay
DNA Fragmentation analysis
Briefly, the cells were plated in 6-well plates 
(0.6×106cell/well) , incubated for 24 hours, and then 
transfected with pcDNA3.1/cdtB or pcDNA3.1 for 48 
hours in the absence of serum.  After washing the cells 
twice with PBS, adherent cells were trypsinized and were 
harvested then lysed in 200 μl cell lysis buffer by stirring 
with a wide-bore pipette tip. 10 μl RNAase A solution was 
added, mixed well and incubated at 37°C for 120 minutes. 
After adding phenol / chloroform and centrifugation, the 
supernatant was collected and treated with 1000 μl of 
100% ethanol for overnight. Centrifuge was performed at 
-4 °C for 10 minutes at 13,000rpm. The supernatant was 
discarded and treated with 100μl 75% EtOH by gently 
mixing. After centrifugation (2 minutes at   13000rpm), 
the supernatant was discarded and the pellet was air 
dried. The DNA pellet was dissolved in 30μL TE buffer 
(100 mM Tris-Cl pH7.4 and 10 mM EDTA pH8.0) and 
incubated for 1 hour at 37°C. The fragmented DNA was 
resolved on 2% agarose gels and electrophoresed for 180 
minutes at 30 V and the bands were detected by UV light 
and documented by photography.
Terminal deoxyribonucleotidyl transferase-mediated 
dUTP nick end labeling (TUNEL) assay.
Table 1. List of Primers Used to Confirm Cloning and Expiration cdt B
Primer Sequence
Specific (CdtB) F: 5 ′-ACCATGCAATGGGTAAAGCAATTA- 3′
Specific (CdtB) R: 5′ -CACGAACAAAACTAACAGGAAAAT- 3′
Universal pcDNA3.1 F: 5′-TAATACGACTCACTATAGG- 3′
Universal pcDNA3.1 R: 5′-TAGAGGCACAGTCGG- 3′
RT-PCR(Cdt B) F: 5′-CAACAACACAATTCCAACCC-3′
RT-PCR(Cdt B) R: 5′-GGCGATACCTGTCCATTCTT-3′
RT-PCR(B-actin) F: 5′-GCATGGGTCAGAAGGATTC-3′
RT-PCR(B-actin) R: 5′-GGCTACTTAGGGTGAGGATG-3′
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Tunel (terminal deoxynucleotide transferase 
[TdTJ-mediated digoxigenin-uridine triphosphate 
[dig-UTP] nick-end labeling;) was performed to measure 
3’-hydroxyI ends of DNA fragments formed during 
programmed cell death ( i.e., apoptosis).  A549 cells were 
plated in 6-well plates and treated with pcDNA3.1/cdtB 
and incubated for 36h at 37oC in a 5% CO2 incubator. 
Control or apoptosis-induced cells were trypsinized, 
collected, then centrifuged (5 min, 2000 rpm) and 
resuspended in 100 μl PBS (phosphate buffered saline).
Cells added to the poly-L-lysine-coated slides and fixed in 
4% paraformaldehyde at room temperature for 20 min. To 
detect nuclei with DNA fragmentation, a TUNEL-staining 
method was performed using a DeadEnd™ Colorimetric 
TUNEL System (Promega Corporation, Madison, WI, 
USA) according to the manufacturer’s instructions. 
Finally the cells on the cover slip were dehydrated, and 
observed under a light microscope.
Cell cycle analysis
Cells were harvested by trypsinization, suspended 2 
×104 cells in 0.5 mL PBS and aspirated several times to 
obtain a mono-dispersed cell suspension with minimal 
cell aggregation.  Then they were fixed for 20 min on ice 
with 4.5 mL of 70% ethanol and kept for at least 2 h at 
4°C . Ethanol thoroughly was decanted by centrifugation 
for 5 min at 300g and subsequently resuspended in 0.5 
ml of propidium iodide (PI) solution (3.8 mM sodium 
citrate, 0.3% NP40, 0.05 mg ml−1 PI, 0.02 mg ml−1 
RNase) in PBS for 2 h at 4°C. Flow cytometric analysis 
was performed using a flow cytometer (Partec CyFlow 
Space, Germany). The distribution of cells in different 
cell cycle phases was analyzed using Flomax software
Caspase 9 assay
In brief, 0.6 × 106cells per well of 6-well plate was 
seeded and kept overnight for attachment. Next day cells 
were transfected with pcDNA3.1/cdtB and incubated 
for 36 h. Following incubation, control and toxin treated 
cells were harvested resuspended in 50 μl lysis buffer and 
Figure 1. Verify Cloning cdtB into pcDNA3.1. and Ex-
pression of CdtB in Transfected Cell. A: Amplification 
of cdtB by Specific Primer (lane1) and Universal Primer 
(lane2). B: Expression of cdtB in A549 Cells Identified 
by RT-PCR. B-actin Served as Internal Control.1: Cell, 
2: Treated with pcDNA3.1, 3: Treated with pcDNA3.1/
cdtB
Figure 2. Inhibition of A549 Cell Proliferation by pcDNA3.1/cdtB in a Time Dependent Manner. A: Morphology 
of A549 Cells Transfected with pcDNA3.1/cdtB Different Time. B: Cell Viability was Determined by MTT Assay 
after 24 h, 48h, and 72h which Significantly Reduced in pcDNA3.1+/cdtB Group Compared to Medium Alone, pcD-
NA3.1+ group: p<0.01.C: Effect of pcDNA3.1/cdtB on A549 Cell Count. C: Graph Showing % Cell Viability. p<0.01.
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incubated for 10 minutes. Caspase 9 activity was measured 
by colorimetric assay according to the manufacturer’s 
instructions.  Abcam’s Caspase 9 assay Kit (Colorimetric) 
prepares a simple method for assaying the activity of 
caspase that recognize the sequence LEHD. In this assay 
cleavage from labeled substrate LEHD-p-NA produces 
chromophore p-nitroanilide (p-NA) that the p-NA light 
emission can be quantified using a spectrophotometer at 
405 nm. The data were expressed as average percentages 
of the absorption. 
Statistical analysis
Comparisons among different groups were performed 
with the Student t-test and one-way ANOVA using 
the SPSS software. P<0.01 was defined statistically 
significant.
Results
Verify cloning cdtB into pcDNA3.1+ and expression 
of CdtB in transfected cell line
The desired gene fragment has 830 nucleotides and 
it was successfully amplified and cloned into pcDNA 
3.1(+) vector with enzymatic digestion. The construct 
was confirmed by colony PCR, restriction analysis and 
sequencing. As shown in Figure 1, successful expression 
of cdtB was detected in transfected A549 cell line with 
pcDNA3.1/cdtB by produce cDNA from cdtB mRNA 
using reverse transcriptase and poly-dT primers, followed 
by PCR using cdtB specific primers. 
The effects of the Cytolethal distending toxin (CdtB) on 
the morphology of the cells
Upon the incubation of cells with toxin, for 24 h, 
48h, and 72h apoptotic cells were seen. As shown in 
figure 2A it is also clear that the most common apoptotic 
morphological changes observed in cells included 
chromatin condensation, loss of normal shape.
The effects of the Cytolethal distending toxin (c) on the 
A549 cell line growth and proliferation
A549, human lung adenocarcinoma cells were assayed 
for cell viability after treatment with the pcDNA3.1/cdtB. 
The results of MTT assay and trypan blue dye revealed 
that transfected with pcDNA3.1/cdtB significantly reduced 
cell viability in time-dependent manner compared to the 
control groups (P<0.001) (Fig. 2B, C) 
Apoptosis induction by Cytolethal distending toxin (CdtB) 
in human lung adenocarcinoma A549 cell line
To investigate DNA fragmentation as hallmark feature 
of apoptosis we studied internucleosomal DNA cleavage 
using DNA fragmentation analysis. In figure 3B, it appear 
that CdtB leads to decrease in the total genomic DNA. 
However, clear DNA ladder pattern was not observed in 
this cell line. Also, TUNEL staining revealed apoptotic 
cells as nuclei with considerable apoptosis was induced in 
transfected cells compared with (untreated cells) controls. 
 
Figure 3. CdtB Induces Apoptosis in A549 Cells. A: Colorimetric TUNEL Assay of A549 Cells Following 36 h Treatment. 
In Contrast to the Untreated Cells and pcDNA3.1+ Control, Some Apoptotic Bodies (Brown Nuclei Stained) were Seen in the 
Transfected Cells with pcDNA3.1+/cdtB. B: Electrophoretic Analysis of Fragmented DNA. M: Ladder, 1: Control Cells, 2: 
pcDNA3.1+Transfected Cell, 3: pcDNA3.1+/cdtB Transfected Cell after 72h. C: Cell Cycle Analysis of A549 Cells Transfected 
with pcDNA3.1+/cdtB for 48h. As a Control, Cells were Transfected with pcDNA3.1+ for 48h. Cells were Fixed with Ethanol, 
Stained by Propidium Iodide to Quantify Cellular DNA, and 20,000 Cells were Counted.
Asian Pacific Journal of Cancer Prevention, Vol17, Cancer Control in Western Asia Special Issue, 2016 303
DOI:http://dx.doi.org/10.7314/APJCP.2016.17.S3.299 
The Apoptotic Effect of B Subunit of Bacterial Cytolethal Distending Toxin on A549 Lung Cancer Cell Line
The DNA fragmentation analysis and TUNEL data 
were in agreement with the flow cytometry results. Cell 
apoptosis was evaluated using flow cytometric analysis. 
As shown in figure 3 the percentage of apoptotic cells 
significantly increased in the pcDNA3.1+/cdtB group 
(63.4%), compared to the pcDNA3.1+16.5%), or medium 
alone (8.2%) groups.
Caspase9 mediated CdtB induced apoptosis 
We measured the changes in caspase 9 activity in A549 
cell line after cdtB construct transfection. As shown in 
figure 4, a significant increase in activity of caspase-9 was 
observed cdtB transfected cells after 36 h, suggesting that 
subunit B is inducing apoptosis in A549 cells by intrinsic 
pathway via caspase-9 induction.
The effect of CdtB on the cycle cycle
The effect of CdtB on the cell cycle progression 
was studied in A549 cells. Propidium iodide staining 
demonstrated that treatment with pcDNA3.1+/cdtB 
induced apoptosis however without any cell cycle arrest 
in the G2/M phase (Figure 2). pcDNA3.1+ was used as a 
control showed any effect on the cell cycle and apoptosis. 
PI staining and flow cytometry analysis was estimated the 
quantification of dead cells (sub-G1) and cells in different 
phases of the cell cycle in the total cell population (Figure 
3C).  
Discussion
During the past decade, bacteria have extensively 
studied for their biomedical applications in cancer therapy 
(Bandala et al., 2013). Live and attenuated bacteria can all 
be antitumor agents that have been emerged as potential 
strategies (Bermudes et al., 2002). Furthermore, bacterial 
toxins are considered as one of the promising cancer 
treatments (Liu et al., 2014).
For example, Shiga toxin, inhibit tumor growth 
in mouse xenograft models (Engedal et al., 2011). 
Diphtheria toxin inhibits protein synthesis, resulting 
in cell lysis and/or induction of apoptosis (Frankel et 
al., 2002). Like DT, Pseudomonas exotoxin A inhibits 
protein synthesis that makes it a potential candidate 
for targeted cancer therapy (Pastan, 1997) In addition, 
Clostridium perfringens enterotoxin (CPE) displays 
cytotoxic activity on pancreatic cancer cells and induces 
tumor necrosis in vivo (Michl et al., 2001). It is being 
investigated for colon, breast and gastric cancers (Hough 
et al., 2000 , Kominsky et al., 2004). 
These findings have strongly recommended the 
application of bacterial toxins as potential cancer 
therapeutic agents. Previous studies examined the 
antitumor potential of a recombinant plasmid DNA 
expressing in several cancer cell lines in which successful 
expression of insert and the reduction of cancer growth 
were observed (Mizrahi et al., 2010 ,Wang et al., 2012). 
Therefore, in this study, attention was focused on a 
plasmid DNA vector-based strategy and also evaluating 
the effects of cdtB derived from Aggregatibacter 
actinomycetemcomitans on apoptosis, cell cycle, and 
their underlying mechanisms in A549, a human lung 
adenocarcinoma cell line. Some investigators have 
demonstrated that CdtB-associated deoxyribonuclease 
(DNase) activity is responsible for Cdt-induced cell 
cycle arrest, suggesting that DNase activity is essential 
for the Cdt toxicity. For example, in several studies on 
Cdt from A. actinomycetemcomitans, cdtA, cdtB and 
cdtC genes were cloned and purified and then, function 
of their gene products was investigated (Saiki et al., 2001 
, Nishihara and Koseki, 2004). Effect of CdtB (rcdtB) 
protein into gingival squamous cell carcinoma cells 
using a BioPORTER as an in vitro system for delivery and 
also effects of cdtB gene transfection with sonoporation 
on the viability of cells confirmed apoptosis following 
delivery of those molecules in cells (Nishihara and 
Koseki, 2004 ,Yamamoto et al., 2004).Cheng-Kuo Lai 
et all., have attempted to use His-tagged CdtB subunit 
along with chitosan/heparin nanoparticle vehicle system 
for delivering transfected into gastric cancer cells. The 
findings confirmed nanoparticle–CdtB-induced cell death 
of gastric cancer cells due to DSBs  and G2/M cell-cycle 
arrest, followed by apoptosis (Lai et al., 2014). In another 
study, Wising C et al (2010) reported that, toxic properties 
of replication deficient adenovirus type 5 (Ad5) vector 
expressing CdtB cause loss of cell viability, morphologic 
changes, and cell cycle arrest on HeLa cells. In the present 
study cdt B was successfully amplified by PCR and cloned 
in pcDNA 3.1(+) vector with enzymatic digestion. The 
construct was confirmed by sequencing. The expression of 
cdtB in cells is detectable on the mRNA level. Decreased 
viability of A549 cells showed by our data from trypan 
blue and MTT test with clear difference between control 
cells and transfected cell with cdtB-expressing vector, and 
also TUNEL assay confirmed slightly increased numbers 
of apoptotic A549 cells after treatment. However, results 
of cell cycle analysis by flow cytometry did not show 
cdtB can induce G2 cell cycle arrest of A549 cells same 
previous study and But rather high levels induction of ap-
optosis and cell death in was observed. To gain insight into 
the molecular mechanism involved in cdtB induced ap-
optosis, the activation of caspase-9 was assessed in A549 
cells. Our results confirmed activation of caspase-9 which 
causes cleave inactive procaspase-3 to active caspase-3, 
thereby providing a link between the mitochondria and cdt 
B induced apoptosis in A549 cells. The present findings 
 
Figure 4. Changes in the Level of Caspase9 Activity at 
36h after Transfection. ***: p<0.01
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provide evidence that pcDNA3.1 (+)/cdtB vector has 
a significant effect on arresting cell cycle and inducing 
apoptosis in A549 cells, similar to changes demonstrated 
in cells treated with holotoxin CDT. Therefore, cdtB may 
have a potentially promising application against non-small 
cell lung cancer. However, expression of the protein should 
be targeted for prevention of damage to the normal cells.
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